While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

The hepatitis A virus (HAV) is one of the main causes of viral hepatitis and is responsible for an estimated 159,000 ...

Hepatitis C is a major public health concern due to its high rates of infection and mortality. Recent breakthroughs in pharmaceuticals not only have the potential to cure hepatitis C but could also ...

A Melbourne doctor's license has been restricted under an emergency order after tests confirmed three of her patients ...

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular carcinoma (HCC) development.

Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January 2025, Atea is initiating a global Phase 3 program and expects patient ...

Atea Pharmaceuticals (AVIR) announced the poster presentation of bemnifosbuvir preclinical data at the 38th International Conference on ...

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for ...

Allan from Maidenhead believes testing people for the virus when they visit A&E will help save lives. US cuts send South Africa's HIV treatment 'off a cliff' The US axes vital HIV/Aids funding ...

Explore diffuse large B-cell lymphoma — symptoms, causes, diagnosis, treatment options, and prevention. Learn about its types ...

Hepatitis B affects the liver and is caused by hepatitis B virus. It can be transmitted during birth, during sex and through blood-to-blood contact. Hepatitis B is diagnosed by blood test with ...

The classes of antiretroviral therapy drugs attack the HIV virus at various points in the duplication process to prevent it from making copies of itself. Taking an ART cocktail of drugs from ...